Page last updated: 2024-08-26

paxilline and Carcinoma, Lobular

paxilline has been researched along with Carcinoma, Lobular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Athanassiadou, AM; Athanassiadou, P; Kyriakidou, V; Lagoudianakis, E; Manouras, A; Panousis, D; Pappas, A; Patsouris, E; Voulgaris, Z; Xepapadakis, G	1

Other Studies

1 other study(ies) available for paxilline and Carcinoma, Lobular

Article	Year
The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors. European journal of gynaecological oncology, 2011, Volume: 32, Issue:2 Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Immunohistochemistry; Middle Aged; Paxillin; Poly-ADP-Ribose Binding Proteins; Polycomb Repressive Complex 2; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Transcription Factors	2011

Article

Year

The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors.

European journal of gynaecological oncology, 2011, Volume: 32, Issue:2

Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Immunohistochemistry; Middle Aged; Paxillin; Poly-ADP-Ribose Binding Proteins; Polycomb Repressive Complex 2; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Transcription Factors

2011